Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency
Nanoparticles (NPs) formulated using poly (D,L-lactide-co-glycolide) (PLGA), a biodegradable, biocompatible, and clinically approved polymer, have been widely used for targeted drug delivery. Here we provide methods for preparing PLGA NPs that encapsulate small interfering RNA (siRNA). The siRNA NPs are formulated using a double-emulsion solvent evaporation technique with the addition of a small amount of the cationic polymer, polyethyleneimine, which significantly increases siRNA encapsulation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:906 |
---|---|
Enthalten in: |
Methods in molecular biology (Clifton, N.J.) - 906(2012) vom: 15., Seite 311-9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pantazis, Panayotis [VerfasserIn] |
---|
Links: |
---|
Themen: |
1SIA8062RS |
---|
Anmerkungen: |
Date Completed 13.11.2012 Date Revised 21.10.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1007/978-1-61779-953-2_25 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM219391327 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM219391327 | ||
003 | DE-627 | ||
005 | 20231224042819.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2012 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/978-1-61779-953-2_25 |2 doi | |
028 | 5 | 2 | |a pubmed24n0731.xml |
035 | |a (DE-627)NLM219391327 | ||
035 | |a (NLM)22791444 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pantazis, Panayotis |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.11.2012 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Nanoparticles (NPs) formulated using poly (D,L-lactide-co-glycolide) (PLGA), a biodegradable, biocompatible, and clinically approved polymer, have been widely used for targeted drug delivery. Here we provide methods for preparing PLGA NPs that encapsulate small interfering RNA (siRNA). The siRNA NPs are formulated using a double-emulsion solvent evaporation technique with the addition of a small amount of the cationic polymer, polyethyleneimine, which significantly increases siRNA encapsulation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Emulsions |2 NLM | |
650 | 7 | |a RNA, Small Interfering |2 NLM | |
650 | 7 | |a Solvents |2 NLM | |
650 | 7 | |a Polylactic Acid-Polyglycolic Acid Copolymer |2 NLM | |
650 | 7 | |a 1SIA8062RS |2 NLM | |
650 | 7 | |a Polyglycolic Acid |2 NLM | |
650 | 7 | |a 26009-03-0 |2 NLM | |
650 | 7 | |a Lactic Acid |2 NLM | |
650 | 7 | |a 33X04XA5AT |2 NLM | |
700 | 1 | |a Dimas, Konstantinos |e verfasserin |4 aut | |
700 | 1 | |a Wyche, James H |e verfasserin |4 aut | |
700 | 1 | |a Anant, Shrikant |e verfasserin |4 aut | |
700 | 1 | |a Houchen, Courtney W |e verfasserin |4 aut | |
700 | 1 | |a Panyam, Jayanth |e verfasserin |4 aut | |
700 | 1 | |a Ramanujam, Rama P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Methods in molecular biology (Clifton, N.J.) |d 1984 |g 906(2012) vom: 15., Seite 311-9 |w (DE-627)NLM074849794 |x 1940-6029 |7 nnns |
773 | 1 | 8 | |g volume:906 |g year:2012 |g day:15 |g pages:311-9 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-61779-953-2_25 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 906 |j 2012 |b 15 |h 311-9 |